Clinical trial
An Open Label Phase I Study Of CP-751,871 In Patients With Multiple Myeloma
NCT01536145 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open Label Phase I Study Of CP-751,871 In Patients With Multiple Myeloma
- Lead sponsor
- Pfizer
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- December 31, 2003
- Completion date
- June 30, 2008
- Enrollment
- 47 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.